UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported)
May 30, 2003
BIOSOURCE INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-21930 77-0340829
(State or other jurisdiction of (Commission File (IRS Employer
incorporation) Number) Identification No.)
542 Flynn Road, Camarillo, California 93012
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (805) 987-0086
ITEM 5. - OTHER EVENTS.
Since the end of the Company's first quarter ended March 31, 2003, the
Company has spent $2,793,000 repurchasing 548,100 shares of its common stock in
accordance with its previously approved stock repurchase program. The largest
repurchase occurred on May 30, 2003, where the Company spent $2,450,000
repurchasing 490,000 shares of its common stock. The Company intends to retire
all common shares repurchased.
ITEM 7. - FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(a) Financial Statements. None.
(b) Pro Forma Financial Information. None.
(c) Exhibits. None.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BIOSOURCE INTERNATIONAL, INC.
June 3, 2003 /s/ Charles C. Best
-----------------------------
Charles C. Best
Chief Financial Officer